CClinicalTrials.gg
Active, not recruitingNCT05216718Updated Sep 11, 2026

Mini-flap BABA (Bilateral Axillo-breast Approach) Robotic Thyroidectomy is Safe

An interventional study of Mini-flap and Conventional flap in Thyroid Nodule, sponsored by Inje University. Active, not recruiting at 1 site in South Korea. Open to participants aged 19 Years to 69 Years. Per ClinicalTrials.gov, last updated 2026-09-11.

Sponsored by Inje University · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
82
Allocation
Randomized
Ages
19 Years to 69 Years
Sex
All
01

Study summary

In this study, a randomized controlled study was conducted between two groups of 40 recipients of conventional flap during BABA robotic-thyroidectomy and 40 recipients of Mini-flap method during BABA robotic-thyroidectomy. In this study, we tried to determine whether the use of Mini-flap can reduce sensory loss and pain after BABA robotic-thyroidectomy.

02

Conditions studied

  • Thyroid Nodule

Browse trials for

Keywords

  • Mini-flap
  • Bilateral axillo-breast approach
  • Da vinci
  • Robot-assisted thyroid surgery
03

Who can participate

Ages eligible
19 Years to 69 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • subjects who will have thyroid surgery
  • subjects who has no evidence of lymph node metastasis on palpation and imaging (cN0)
  • subjects who has thyroid nodule under 4cm (\<cT2)
  • subjects who has no distant metastasis (M0)

Exclusion criteria

Exclusion Criteria:

  • subjects who has clinical evidence of lymph node metastasis (cN1a or cN1b)
  • subjects who has both thyroid nodule
  • subjects who underwent any radiotherapy on neck
  • subjects who has primary hyperparathyroidism
  • subjects who underwent head and neck surgery
  • subjects who disagree to do this trial
04

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Investigator, Outcomes assessor)
Enrollment
82 participants (actual)

Study arms

  • Experimental
    Conventional flap

    BABA robotic-thyroidectomy that using conventional flap

    Procedure: Conventional flap

  • Active comparator
    Mini-flap

    BABA robotic-thyroidectomy that using Mini-flap

    Procedure: Mini-flap

Interventions

  • ProcedureMini-flap

    Mini-flap BABA robotic-thyroidectomy creates flaps up to the cricoid cartilage

  • ProcedureConventional flap

    Conventional flap BABA robotic-thyroidectomy creates flaps up to the thyroid cartilage

05

What researchers measure

Primary outcomes

  1. Postoperative pain measured using a visual analog scale

    Postoperative pain was assessed using a visual analog scale ranging from 0 to 10, with higher scores indicating greater pain.

    Time frame: 2, 24, 48, and 72 hours after surgery

  2. Rescue analgesic use

    Number of additional doses of ketorolac administered for postoperative pain.

    Time frame: 2, 24, 48, and 72 hours after surgery

  3. Change from baseline in sensory function as measured by Semmes-Weinstein monofilaments

    Sensory function was assessed using six Semmes-Weinstein monofilaments to measure pressure detection thresholds in four predefined anatomical regions: the superior anterior neck, inferior anterior neck, right anterior chest, and left anterior chest.

    Time frame: 1 day before surgery and 1, 6 and 12 months after surgery

Secondary outcomes

  1. Incidence of vocal cord palsy

    Check vocal cord palsy that means injury of the recurrent laryngeal nerve with a direct laryngoscope

    Time frame: before surgery, 1 day after surgery, 2, 6 weeks after surgery, 6 month, 1year after surgery

  2. change from baseline in Hypoparathyroidism, as measured by parathyroid hormone level

    check PTH (parathyroid hormone) level

    Time frame: before surgery, 1 day after surgery, 2, 6 weeks after surgery, 6 month, 1year after surgery

06

Study locations

1 site
  • Dong sik Bae
    Busan, South Korea
07

Registry details

Key details

Study ID
NCT05216718
Lead sponsor
Inje University
Responsible party
Dongsik Bae (Associate Professor, Inje University) — Principal investigator
First posted
Jan 31, 2022
Start date
Jan 24, 2022
Primary completion
Jun 30, 2024
Completion
Dec 1, 2026 (estimated)
Last update
Sep 11, 2026

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion